While scientists work to develop effective treatments for COVID-19, there is good news on another disease front. This month the U.S. Food and Drug Administration granted formal approval to an antibody cocktail from the pharmaceutical company Regeneron that’s been shown to reduce an Ebola patient’s chances of dying dramatically.
#Snapshots September 2020
We Are Continuing to Fight COVID-19 Around the World Around the world, we’re continuing to help people in need...
Lightning Strikes Twice as Doctors Tackle Malnutrition in South Sudan
When toddler Nyalak Kuon Mut was struck by lightning in June, she was already suffering from severe acute malnutrition....